{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:48:52Z","timestamp":1791136132636,"version":"4.1.0"},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":999,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2003,5]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      A\n                      <jats:sc>bstract<\/jats:sc>\n                      :\n                    <\/jats:bold>\n                    Recently, we and others could define the molecular cause of the rare disease congenital amegakaryocytic thrombocytopenia (CAMT) as mutations in the\n                    <jats:italic>c\u2010mpl<\/jats:italic>\n                    gene (Blood 97: 139, 2001). We proposed that\n                    <jats:italic>c\u2010mpl<\/jats:italic>\n                    mutations are the cause not only for the hypomegakaryocytic thrombocytopenia, but also for the development of an aplastic anemia (AA) in patients with CAMT. The effects of thrombopoietin (TPO) on early multipotent hematopoietic progenitors were elucidated by a recent series of\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    studies. Like CAMT patients, mice lacking the TPO receptor c\u2010Mpl demonstrate a major reduction of early hematopoietic progenitor cells of all lineages. However, these mice achieve a normal marrow cellularity and composition, despite the lack of megakaryocytes. On the other hand, the incidence of development of aplastic anemia in CAMT is not clear owing to difficult and not consistent diagnosis of this disease.\n                  <\/jats:p>","DOI":"10.1111\/j.1749-6632.2003.tb03228.x","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T09:38:02Z","timestamp":1236332282000},"page":"17-25","source":"Crossref","is-referenced-by-count":67,"title":["Thrombopoietin Is Essential for the Maintenance of Normal Hematopoiesis in Humans"],"prefix":"10.1111","volume":"996","author":[{"given":"M.","family":"BALLMAIER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"GERMESHAUSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"KRUKEMEIER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"WELTE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,24]]},"reference":[{"key":"e_1_2_11_2_2","first-page":"519","article-title":"Aplastic anemia in childhood","volume":"1","author":"O'Gorman Hughes D.","year":"1974","journal-title":"III. Constitutional aplastic anaemia and related cytopenias. Med. J. Austr."},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199022000-00020"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.1.139"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.6.3132"},{"key":"e_1_2_11_6_2","first-page":"44a","article-title":"Defective TPO\u2010reactivity in congenital amegakaryocytic thrombocytopenia [abstract]","volume":"94","author":"Ballmaier M.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02175.x"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004390000357"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03455.x"},{"key":"e_1_2_11_10_2","unstructured":"Alter B.P. & N.S. Young. 1998. The bone marrow failure syndromes.InNathan and Oski's Hematology of Infancy and Childhood 5th ed. D.G. Nathan & S.H. Orkin Eds. W.B. Saunders. Philadelphia PA."},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.11.4544.bloodjournal87114544"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.12.4998.bloodjournal87124998"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.2.429.bloodjournal882429"},{"key":"e_1_2_11_14_2","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1182\/blood.V90.6.2282","article-title":"Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38\u2212 bone marrow cells with multilineage potential at the single\u2010cell level: Key role of thrombopoietin","volume":"90","author":"Borge O. J.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.3.803.803"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215430"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530160703"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3241"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.7.2599"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3675"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.1.139"},{"key":"e_1_2_11_22_2","unstructured":"Lubin B.H. 1993. Reference values in infancy and childhood.InHematology of Infancy and Childhood 4th ed. D.G. Nathan & F.A. Oski Eds. W.B. Saunders. Philadelphia PA."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2003.tb03228.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2003.tb03228.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T21:54:22Z","timestamp":1695592462000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2003.tb03228.x"}},"subtitle":["Development of Aplastic Anemia in Patients with Congenital Amegakaryocytic Thrombocytopenia"],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1111\/j.1749-6632.2003.tb03228.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2003.tb03228.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}